Higher Risk Myelodysplastic Syndromes Clinical Trials in Chapel Hill, North Carolina
2 recruitingChapel Hill, North Carolina
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression
Acute Lymphoblastic LeukaemiaHigher Risk Myelodysplastic SyndromesAcute Myeloid Leukaemia
AstraZeneca84 enrolled30 locationsNCT07155226
Recruiting
Phase 2
A Study of AK117 in Combination With Azacitidine in Patients With Myelodysplastic Syndromes
Higher Risk Myelodysplastic Syndromes
Akeso90 enrolled15 locationsNCT06196203